(R)-Methyl 3-(5-bromopyridin-2-yl)-2-((tert-butoxycarbonyl)amino)propanoate, 98%, 1g

2-Amino-1H-isoindole-1,3(2H)-dione, 97.0%, 5g

Alcool benzylique, min 98%, pour la synthèse, 1L, emballage en verre

METHYL 2-ACETOXY-4-BROMOBUTANOATE, 95.0%, 5g

Brevianamide F, 97.0%, 250mg

2-((Tetrahydro-2H-pyran-4-yl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 250mg

(1-cyclopentylcyclopropyl)amine hydrochloride, 95.0%, 1g

N-Acetyl-L-carnosine, 97.0%, 10g

Potassium bicarbonate, 99.0%, 10kg

Colonne capillaire GC ROTI®Cap-1, 10 m, 0,25 mm, 0,10 µm, 1 pièce(s)

2-chloro-4,5,6,7-tetrahydro-1,3-benzothiazole, 95.0%, 2.5g

1-(2-aminoethoxy)-2,3-dichlorobenzene hydrochloride, 500mg

tert-Butyl 2-(chloromethyl)-2-(hydroxymethyl)pyrrolidine-1-carboxylate, 97%, 100mg